Related Experiment Videos
Possible cefotaxime-induced Stevens-Johnson syndrome
Evagelos N Liberopoulos1, George L Liamis, Moses S Elisaf
1Department of Internal Medicine, School of Medicine, University of Ioannina, Ioannina, Greece.
The Annals of Pharmacotherapy
|May 30, 2003
Summary
This case report details a possible Stevens-Johnson syndrome (SJS) reaction in a patient treated with cefotaxime for a urinary tract infection. The symptoms resolved after discontinuing the antibiotic, suggesting a potential drug-induced adverse event.
Area of Science:
- Pharmacology
- Dermatology
- Infectious Diseases
Background:
- Stevens-Johnson syndrome (SJS) is a severe mucocutaneous adverse drug reaction.
- Cephalosporins, including cefotaxime, have been implicated in SJS cases.
- Early identification and drug withdrawal are crucial for managing SJS.
Observation:
- A 72-year-old woman presented with fever, skin erosions, and mucosal blisters post-cefotaxime administration for a urinary tract infection.
- Clinical presentation was consistent with Stevens-Johnson syndrome.
- Symptoms resolved after cefotaxime was discontinued, with other causes ruled out.
Findings:
- Causality assessment suggested a possible association between cefotaxime and SJS.
- This report is the first detailed case of cefotaxime-induced SJS in the literature.
- An immunologically mediated reaction is the suspected mechanism.
Implications:
- This case highlights the potential for cefotaxime to cause SJS.
- Further research and case reports are needed to confirm the causal relationship.
- Clinicians should maintain a high index of suspicion for SJS with cefotaxime use.